Abstract
The use of chloroquine and hydroxychloroquine in the tough time of COVID-19 has gained much attention. The production and use of these drugs has drastically increased in the past few months. However, it is important to know that retinal toxicity is a very rare side effect of these therapies that can lead to permanent vision loss. The mechanism is however unclear, but this toxicity might depend on the tolerance of the subjects exposed. It is important to choose the appropriate dosage which should be customized as per the patient’s condition, age, body weight and comorbidities. Also, to avoid the occurrence of retinopathy, eye examination and ophthalmic screening for the patients being administered these drugs should be done. This review discusses the risk determinants, the clinical presentations and screening techniques of retinal toxicity.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
